{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:42:15Z","timestamp":1791639735098,"version":"4.3.4"},"reference-count":123,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jacc.2019.12.072","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T13:59:59Z","timestamp":1586786399000},"page":"1804-1818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":340,"title":["Primary and Secondary Prevention of\u00a0Ischemic Stroke and Cerebral\u00a0Hemorrhage"],"prefix":"10.1016","volume":"75","author":[{"given":"Hans-Christoph","family":"Diener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.12.072_bib1","article-title":"Cardiovascular care of patients with stroke and high risk of stroke: the need for interdisciplinary action: a consensus report from the European Society of Cardiology Cardiovascular Round Table","author":"Doehner","year":"2019","journal-title":"Europ J Prevent Cardiol"},{"key":"10.1016\/j.jacc.2019.12.072_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib3","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/CIRCULATIONAHA.112.103234","article-title":"Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries","volume":"126","author":"Dehghan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.12.072_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.12.072_bib5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/WNL.0b013e3181c34b58","article-title":"Physical activity and risk of ischemic stroke in the Northern Manhattan Study","volume":"73","author":"Willey","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2019.12.072_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.7326\/M19-0341","article-title":"Effects of Nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map","volume":"171","author":"Khan","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib7","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib8","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jacc.2019.12.072_bib9","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.12.072_bib10","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.12.072_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCULATIONAHA.108.191305","volume":"119","author":"Skyler","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.12.072_bib12","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1806802","article-title":"Intensive glucose control in patients with type 2 diabetes - 15-year follow-up","author":"Reaven","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2016.04.163","article-title":"Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: a meta-analysis of data from 58,160 patients in 13 randomized controlled trials","volume":"218","author":"Fang","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2019.12.072_bib14","first-page":"3021","article-title":"Cardiovascular outcome trials of the newer anti-diabetic medications","volume":"39","author":"Acharya","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2019.12.072_bib15","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.018","article-title":"Lipid lowering therapy, low-density lipoprotein level and risk of intracerebral hemorrhage - a meta-analysis","volume":"28","author":"Judge","year":"2019","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2019.12.072_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2018.12.007","article-title":"Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: a systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants","volume":"210","author":"Yebyo","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.12.072_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.phrs.2019.03.021","article-title":"Cardiovascular events with PCSK9 inhibitors: an updated meta-analysis of randomised controlled trials","volume":"143","author":"Casula","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2019.12.072_bib20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.12.072_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.12.072_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.12.072_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib24","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2019.12.072_bib26","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1161\/STROKEAHA.109.561837","article-title":"Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study","volume":"41","author":"Marquardt","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-158-9-201305070-00007","article-title":"Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis","volume":"158","author":"Raman","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib28","article-title":"Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: one-year interim results of SPACE\u20132","author":"Reiff","year":"2019","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11910-018-0888-5","article-title":"Asymptomatic carotid stenosis: intervention or best medical therapy?","volume":"18","author":"Gaba","year":"2018","journal-title":"Cur Neurol Neurosci Rep"},{"key":"10.1016\/j.jacc.2019.12.072_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.48.4.896","article-title":"Outcome of asymptomatic patients with carotid disease. Asymptomatic Cervical Bruit Study Group","volume":"48","author":"Mackey","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2019.12.072_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejvs.2018.09.018","article-title":"Optimal antiplatelet therapy in moderate to severe asymptomatic and symptomatic carotid stenosis: a comprehensive review of the literature","volume":"57","author":"Murphy","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2019.12.072_bib32","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib34","article-title":"Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2019.12.072_bib35","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4244\/EIJ-D-18-00622","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"14","author":"Pristipino","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2019.12.072_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib40","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.12.072_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","article-title":"Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services","volume":"328","author":"Coull","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib44","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","article-title":"Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison","volume":"370","author":"Rothwell","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib45","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","article-title":"One-year risk of stroke after transient ischemic attack or minor stroke","volume":"374","author":"Amarenco","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib46","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","article-title":"Five-year risk of stroke after TIA or minor ischemic stroke","volume":"378","author":"Amarenco","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib47","series-title":"Textbook of Stroke Medicine","first-page":"410","article-title":"Secondary stroke prevention","author":"Diener","year":"2019"},{"key":"10.1016\/j.jacc.2019.12.072_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.115.06480","article-title":"Achieved blood pressure and outcomes in the Secondary Prevention of Small Subcortical Strokes Trial","volume":"67","author":"Odden","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.12.072_bib51","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","article-title":"Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials","volume":"69","author":"Katsanos","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.12.072_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib55","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2019.12.072_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jnnp-2018-318483","article-title":"Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis","volume":"90","author":"Ziff","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2019.12.072_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","article-title":"Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention","volume":"8","author":"Amarenco","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib59","article-title":"Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular disease","author":"Climent","year":"2020","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.jacc.2019.12.072_bib60","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/STROKEAHA.116.013977","article-title":"Pioglitazone for secondary stroke prevention: a systematic review and meta-analysis","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib62","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/STROKEAHA.116.015756","article-title":"Empagliflozin and cerebrovascular events in patients with type 2 diabetes mellitus at high cardiovascular risk","volume":"48","author":"Zinman","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2019.12.072_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.12.072_bib65","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(10)70187-3","article-title":"B\u00a0vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(12)70091-1","article-title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib67","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A\u00a0clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib68","first-page":"71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"524","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor versus aspirin in acute stroke or transient ischemic attack","volume":"375","author":"Johnston","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib70","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib73","doi-asserted-by":"crossref","first-page":"k5130","DOI":"10.1136\/bmj.k5130","article-title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","volume":"363","author":"Prasad","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib74","first-page":"71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"524","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.12.072_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.66.2.255","article-title":"Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin","volume":"65","author":"Algra","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2019.12.072_bib76","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: The MATCH trial results","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib78","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib79","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib80","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.12.072_bib81","first-page":"1812","volume":"50","author":"Greving","year":"2019","journal-title":"Antiplatelet therapy after noncardioembolic stroke. Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib82","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib83","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","article-title":"Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial","volume":"18","author":"Toyoda","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib84","first-page":"1255","article-title":"EAFT (European Atrial Fibrillation Trial) Study Group","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib85","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/01.STR.0000129900.70583.67","article-title":"Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack","volume":"35","author":"Saxena","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib86","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib87","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.12.072_bib88","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1747493017700663","article-title":"Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Ntaios","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib89","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib90","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib91","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/STROKEAHA.116.015770","article-title":"Prediction of early recurrent thromboembolic event and major bleeding in patients with acute stroke and atrial fibrillation by a risk stratification schema: the ALESSA score study","volume":"48","author":"Paciaroni","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1160\/TH16-03-0217","article-title":"Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation","volume":"116","author":"Paciaroni","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2019.12.072_bib93","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1747493016632239","article-title":"Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study","volume":"11","author":"Arihiro","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib96","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib97","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.12.072_bib99","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib101","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib102","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib103","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib104","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2019.12.072_bib106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2396987319841187","article-title":"Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline","volume":"4","author":"Klijn","year":"2019","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jacc.2019.12.072_bib107","first-page":"CD001081","article-title":"Carotid endarterectomy for symptomatic carotid stenosis","volume":"6","author":"Orrapin","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.12.072_bib108","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(98)11415-0","article-title":"Prediction on benefit from carotid endarterectomy in individual patients: a risk-modelling study","volume":"353","author":"Rothwell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib109","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/01.wnl.0000176036.07558.82","article-title":"Carotid endarterectomy\u2014an evidence-based review: report of the Therapeutics and Technology Assessment\u00a0Subcommittee of the American Academy of Neurology","volume":"65","author":"Chaturvedi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2019.12.072_bib110","first-page":"CD000515","article-title":"Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis","volume":"2","author":"Bonati","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.12.072_bib111","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(14)61184-3","article-title":"Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial","volume":"385","author":"Bonati","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib112","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505215","article-title":"Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis","volume":"374","author":"Brott","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib113","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(06)69122-8","article-title":"30\u00a0day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial","volume":"368","author":"Ringleb","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.12.072_bib114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1474-4422(08)70024-3","article-title":"Clinical and angiographic risk factors for stroke and death within 30\u00a0days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study","volume":"7","author":"Stingele","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib115","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa061752","article-title":"Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis","volume":"355","author":"Mas","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib117","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(19)30149-8","article-title":"Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis","volume":"18","author":"Markus","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib118","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCULATIONAHA.105.578229","article-title":"Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis","volume":"113","author":"Kasner","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.12.072_bib120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.12.072_bib121","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2019.12.072_bib122","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(19)30184-X","article-title":"Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases:\u00a0subgroup analyses of the RESTART randomised,\u00a0open-label trial","volume":"18","author":"Al-Shahi Salman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2019.12.072_bib123","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/S0140-6736(19)30840-2","article-title":"Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial","volume":"393","year":"2019","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720344260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720344260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:32:23Z","timestamp":1760016743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720344260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":123,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0735109720344260"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.12.072","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary and Secondary Prevention of\u00a0Ischemic Stroke and Cerebral\u00a0Hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.12.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}